Press Releases
Meeting between KEFEA and the HIO Discussions focused on the GESY and patients’ access to innovative medicines.
The implementation of a modern and sustainable healthcare system, which will guarantee the provision of top-level health services and at the same time enable equitable access to innovative medicines for all patients, was the subject of discussion in a meeting between...
New Code of Practice by KEFEA Includes strict provisions on the promotion of prescription medicines to healthcare professionals.
Stricter provisions on the promotion of prescription medicines to healthcare professionals are among others points included in the revised Code of Practice by the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA). The new Code, which has...
Joanna Kozakou is the new president of KEFEA
Joanna Kozakou, Operations Manager of Sanofi, has assumed the position of President of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), following the departure of Daan Gijbels from Cyprus who will undertake a new position as Area...
KEFEA welcomes the decision for the Medical School operation
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) welcomes the decision to operate the Medical School at the University of Cyprus come September and is pleased that the various obstacles have been overcome. KEFEA also congratulates...
KEFEA: We will not let patients go without medication
In response to reports claiming companies are not providing medication on credit as a result of the unfavourable for our country developments in the economy, the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) assures consumers that the...
Daan Gijbels is the new president of KEFEA
Mr Daan Gijbels, of Dutch descent and Area General Manager for GlaxoSmithKline (Cyprus), is the new president of the Cyprus Association of Research & Development Pharmaceutical Companies (KEFEA). He took over from Jacqueline Anastassiades, General Manager of Merck...
KEFEA met with Giorgos Lillikas
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), met with Presidential Candidate Giorgos Lillikas, within the framework of its meetings with the presidential candidates. "We had a very substantive dialogue with Mr. Lillikas and we...
KEFEA’s position on the drugs pricing system
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) expresses the belief that the change in the pricing policy for medicines, as has been approved by Cabinet, ensures, under the circumstances, the continued availability of the majority...
Creation of a Cypriot network for research and innovation. European IMI programme.
The foundation for creating a network for research and innovation in Cyprus has been set by the meeting for the European Innovative Medicines Initiative (IMI) programme, held on July 3, at the Cyprus Institute of Neurology and Genetics. With a budget of €2 billion,...
KEFEA is strong supporter of GESY
The Cyprus Association of Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) commends the decision of the Cabinet to approve the implementation proposal of a National Health System (GESY) in Cyprus, which was presented by the Ministry of...